Early liver cancer: Concepts, diagnosis, and management

International Journal of Clinical Oncology

Volumn 10, Issue 6, 2005, Pages 384-390

  Yoshida, Hideo ^a   Yoshida, Haruhiko ^a   Shiina, Shuichiro ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Diagnosis; Early HCC; Hepatocellular carcinoma; Management

Indexed keywords

ALPHA FETOPROTEIN; DECARBOXYPROTHROMBIN; GAMMA GLUTAMYL HYDROLASE; GLYPICAN;

ANGIOGRAPHY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER STAGING; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FOLLOW UP; HEALTH CARE COST; HIGH RISK POPULATION; HUMAN; LIVER CANCER; LIVER CELL CARCINOMA; LIVER RESECTION; MOLECULAR BIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

ANTINEOPLASTIC AGENTS; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 29244490577     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10147-005-0537-2     Document Type: Review

References (70)

1. DM Parkin SL Whelan J Ferlay 1997 Cancer incidence in five continents International Agency for Research on Cancer Lyon
2. SD Taylor-Robinson GR Foster S Arora 1997 Increase in primary liver cancer in the UK, 1979-94 Lancet 350 1142 1143
3. HB El-Serag AC Mason 1999 Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745 750
4. MP Coleman G Gatta A Verdecchia 2003 EUROCARE-3 summary: cancer survival in Europe at the end of the twentieth century Ann Oncol 14 Suppl 5 v128 149
5. Ries LAG, Eisner MP, Kosary CL, et al. (2004) SEER cancer statistics review
6. R Tateishi H Yoshida S Shiina 2004 Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients Gut 54 419 425
7. H Yoshida Y Shiratori M Moriyama 1999 Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of hepatocarcinogenesis by interferon therapy Ann Intern Med 131 174 181
8. H Yoshida R Tateishi Y Arakawa 2004 Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C Gut 53 425 430
9. Y Shiratori Y Ito O Yokosuka 2005 Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival Ann Intern Med 142 105 114
10. M Omata H Yoshida 2004 Prevention and treatment of hepatocellular carcinoma Liver Transpl 10 S111 114
11. R Tateishi S Shiina T Teratani 2005 Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases Cancer 103 1201 1209
12. Y Koike Y Shiratori S Sato 2000 Risk factors for recurring hepatocellular carcinoma differ according to infected hepatitis virus - an analysis of 236 consecutive patients with a single lesion Hepatology 32 1216 1223
13. M Omata R Tateishi H Yoshida 2004 Treatment of hepatocellular carcinoma by percutaneous tumor ablation methods: ethanol injection therapy and radiofrequency ablation Gastroenterology 127 S159 166
14. V Mazzaferro E Regalia R Doci 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693 699
15. H Bismuth L Chiche R Adam 1993 Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients Ann Surg 218 145 151
16. T Takayama M Makuuchi S Hirohashi 1998 Early hepatocellular carcinoma as an entity with a high rate of surgical cure Hepatology 28 1241 1246
17. T Takayama M Makuuchi S Hirohashi 1990 Malignant transformation of adenomatous hyperplasia to hepatocellular carcinoma Lancet 336 1150 1153
18. M Kojiro T Roskams 2005 Early hepatocellular carcinoma and dysplastic nodules Semin Liver Dis 25 133 142
19. M Sakamoto S Hirohashi Y Shimosato 1991 Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma Hum Pathol 22 172 178
20. M Kojiro 2004 Focus on dysplastic nodules and early hepatocellular carcinoma: an Eastern point of view Liver Transpl 10 S3 8
21. V Paradis I Bieche D Dargere 2003 Molecular profiling of hepatocellular carcinomas (HCC) using a large-scale real-time RT-PCR approach: determination of a molecular diagnostic index Am J Pathol 163 733 741
22. FX Bosch J Ribes J Borras 1999 Epidemiology of primary liver cancer Semin Liver Dis 19 271 285
23. XD Zhou ZY Tang BH Yang 2001 Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma Cancer 91 1479 1486
24. MS Peterson RL Baron 2001 Radiologic diagnosis of hepatocellular carcinoma Clin Liver Dis 5 123 144
25. R Lencioni D Cioni C Bartolozzi 2002 Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound Eur Radiol 12 151 165
26. H Ding M Kudo H Onda 2001 Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT Radiology 221 721 730
27. M Matsuo M Kanematsu Y Inaba 2001 Pre-operative detection of malignant hepatic tumours: value of combined helical CT during arterial portography and biphasic CT during hepatic arteriography Clin Radiol 56 138 145
28. GA Krinsky VS Lee ND Theise 2001 Hepatocellular carcinoma and dysplastic nodules in patients with cirrhosis: prospective diagnosis with MR imaging and explantation correlation Radiology 219 445 454
29. Y Imai T Murakami S Yoshida 2000 Superparamagnetic iron oxide-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading Hepatology 32 205 212
30. MJ Tong LM Blatt VW Kao 2001 Surveillance for hepatocellular carcinoma in patients with chronic viral hepatitis in the United States of America J Gastroenterol Hepatol 16 553 559
31. YC Peng CS Chan GH Chen 1999 The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma Hepatogastroenterology 46 3208 3211
32. MH Nguyen RT Garcia PW Simpson 2002 Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis Hepatology 36 410 417
33. F Trevisani PE D'Intino AM Morselli-Labate 2001 Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status J Hepatol 34 570 575
34. K Shiraki K Takase Y Tameda 1995 A clinical study of lectin-reactive alpha-fetoprotein as an early indicator of hepatocellular carcinoma in the follow-up of cirrhotic patients Hepatology 22 802 807
35. MY Hsieh SN Lu LY Wang 1992 Alpha-fetoprotein in patients with hepatocellular carcinoma after transcatheter arterial embolization J Gastroenterol Hepatol 7 614 617
36. F Nomura M Ishijima K Kuwa 1999 Serum des-gamma-carboxy prothrombin levels determined by a new generation of sensitive immunoassays in patients with small-sized hepatocellular carcinoma Am J Gastroenterol 94 650 654
37. JA Marrero GL Su W Wei 2003 Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients Hepatology 37 1114 1121
38. Y Aoyagi M Oguro M Yanagi 1996 Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma Cancer 77 1781 1786
39. Y Hippo K Watanabe A Watanabe 2004 Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma Cancer Res 64 2418 2423
40. MW Smith ZN Yue GK Geiss 2003 Identification of novel tumor markers in hepatitis C virus-associated hepatocellular carcinoma Cancer Res 63 859 864
41. M Chuma M Sakamoto K Yamazaki 2003 Expression profiling in multistage hepatocarcinogenesis: identification of HSP70 as a molecular marker of early hepatocellular carcinoma Hepatology 37 198 207
42. M Takashima Y Kuramitsu Y Yokoyama 2003 Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus-related hepatocellular carcinoma Proteomics 3 2487 2493
43. FL Green DL Page ID Fleming 2002 Liver (Including Intrahepatic Bile Duct) FL Green AJCC cancer staging manual 6th edn Springer Chicago 131 144
44. K Okuda T Ohtsuki H Obata 1985 Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 918 928
45. The Cancer of the Liver Italian Program (Clip) Investigators 1998 A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients Hepatology 28 751 755
46. JM Llovet C Bru J Bruix 1999 Prognosis of hepatocellular carcinoma: the BCLC staging classification Semin Liver Dis 19 329 338
47. M Kudo H Chung S Haji 2004 Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score Hepatology 40 1396 1405
48. R Tateishi H Yoshida S Shiina 2005 Proposal of a new prognostic model for hepatocellular carcinoma: an analysis of 403 patients Gut 54 419 425
49. J Bruix M Sherman JM Llovet 2001 Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 421 430
50. TJ Song EW Ip Y Fong 2004 Hepatocellular carcinoma: current surgical management Gastroenterology 127 S248 260
51. G Ercolani GL Grazi M Ravaioli 2003 Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence Ann Surg 237 536 543
52. RTP Poon ST Fan J Wong 2000 Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma Ann Surg 232 10 24
53. JM Llovet J Fuster J Bruix 1999 Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation Hepatology 30 1434 1440
54. S Rossi M Di Stasi E Buscarini 1996 Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer AJR Am J Roentgenol 167 759 768
55. L Buscarini E Buscarini M Di Stasi 2001 Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results Eur Radiol 11 914 921
56. S Shiina T Teratani S Obi 2005 A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma Gastroenterology 129 122 130
57. M Akamatsu H Yoshida S Obi 2004 Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial Liver Int 24 625 629
58. JM Llovet J Bruix 2003 Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival Hepatology 37 429 442
59. T Chiba K Tokuuye Y Matsuzaki 2005 Proton beam therapy for hepatocellular carcinoma: a retrospective review of 162 patients Clin Cancer Res 11 3799 3805
60. JF Geschwind R Salem BI Carr 2004 Yttrium-90 microspheres for the treatment of hepatocellular carcinoma Gastroenterology 127 S194 205
61. AG Visioli IH Rivens GR ter Haar 1999 Preliminary results of a phase I dose escalation clinical trial using focused ultrasound in the treatment of localised tumours Eur J Ultrasound 9 11 18
62. MH Chang CJ Chen MS Lai 1997 Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group N Engl J Med 336 1855 1859
63. SM Lin IS Sheen RN Chien 1999 Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection Hepatology 29 971 975
64. A Matsumoto E Tanaka A Rokuhara 2005 Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: a multicenter retrospective study of 2795 patients Hepatol Res 32 173 184
65. M Omata Y Shiratori 2000 Long-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C J Gastroenterol Hepatol 15 Suppl E134 140
66. S Nishiguchi T Kuroki S Nakatani 1995 Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis Lancet 346 1051 1055
67. International interferon-alpha hepatocellular carcinoma study group 1998 Effect of interferon-alpha on progression of cirrhosis to hepatocellular carcinoma: a retrospective cohort study Lancet 351 1535 1539
68. Y Arase K Ikeda N Murashima 1997 The long term efficacy of glycyrrhizin in chronic hepatitis C patients Cancer 79 1494 1500
69. Y Muto H Moriwaki M Ninomiya 1996 Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study Group N Engl J Med 334 1561 1567
70. International Union Against Cancer (UICC) 2002 Liver LH Sobin CH Wittekind TNM Classification of Malignant tumours 6th ed. Wiley-Liss New York 81 83